Kegg medicus dgroup
| DG01985 | |
| DG番号 | DG01985 |
| 分類 | DGroup |
| 名称 | Disease modifying anti-rheumatic drug (DMARD) TYPE Class |
| ステム | - |
| 構造式 |  |
| メンバー | DG01912 Gold preparations D00992 Gold sodium thiomalate (USP); Sodium aurothiomalate (JP18) D08521 Sodium aurothiosulfate (INN) D00237 Auranofin (JP18/USAN/INN) D00991 Aurothioglucose (USP) D07478 Aurotioprol DG00763 Penicillamine D00496 Penicillamine (JAN/USP/INN) D08330 Penicillamine hydrochloride D01809 Bucillamine (JP18/INN) D01146 Iguratimod (JAN/INN) D00448 Sulfasalazine (USP/INN); Salazosulfapyridine (JP18) D01395 Actarit (JAN/INN) D00749 Leflunomide (JAN/USP/INN) DG00439 Tacrolimus D08556 Tacrolimus (INN) D00107 Tacrolimus (USP/INN); Tacrolimus hydrate (JP18) DG00743 Azathioprine D00238 Azathioprine (JP18/USP/INN) D03033 Azathioprine sodium (USP) DG00681 Methotrexate D00142 Methotrexate (JP18/USP/INN) D02115 Methotrexate sodium D01392 Mizoribine (JP18/INN) DG02020 JAK inhibitor DG00719 Ruxolitinib D09959 Ruxolitinib (USAN/INN) D09960 Ruxolitinib phosphate (JAN/USAN) DG02968 Fedratinib D10630 Fedratinib (USAN/INN) D11296 Fedratinib hydrochloride (USAN); Fedratinib hydrochloride hydrate (JAN) D11768 Pacritinib (USAN/INN) DG00742 Tofacitinib D09970 Tofacitinib (USAN) D09783 Tofacitinib citrate (JAN/USAN) D10308 Baricitinib (JAN/USAN/INN) DG02829 Upadacitinib D10994 Upadacitinib (USAN/INN) D10995 Upadacitinib tartrate (USAN) D11048 Upadacitinib hydrate (JAN) DG01991 Filgotinib D10871 Filgotinib (USAN/INN) D10872 Filgotinib hydrochloride (USAN) D11106 Filgotinib maleate (JAN/USAN) DG02833 Itacitinib D10944 Itacitinib (USAN/INN) D10945 Itacitinib adipate (JAN/USAN) DG01853 Peficitinib D10653 Peficitinib (USAN/INN) D10721 Peficitinib hydrobromide (JAN/USAN) D11400 Abrocitinib (JAN/USAN) D11046 Delgocitinib (JAN/USAN/INN) DG01366 Momelotinib D10315 Momelotinib (USAN/INN) D10358 Momelotinib dihydrochloride (USAN) D10889 Momelotinib hydrochloride hydrate (JAN) DG02005 Oclacitinib D10141 Oclacitinib (USAN) D10142 Oclacitinib maleate (USAN) DG03044 Brepocitinib D11537 Brepocitinib (USAN) D11538 Brepocitinib tosylate (USAN) DG03058 Zotiraciclib D11599 Zotiraciclib (USAN) D11600 Zotiraciclib citrate (USAN) DG03080 Gusacitinib D11676 Gusacitinib (USAN/INN) D11677 Gusacitinib hydrochloride (USAN) DG03114 Deuruxolitinib D11866 Deuruxolitinib (USAN) D11867 Deuruxolitinib phosphate (USAN) DG03175 Ivarmacitinib D12211 Ivarmacitinib (USAN) D12212 Ivarmacitinib sulfate (USAN) DG03264 Povorcitinib D12575 Povorcitinib (USAN/INN) D12576 Povorcitinib phosphate (USAN) D10365 Gandotinib (USAN/INN) D10585 Decernotinib (USAN/INN) D10728 Solcitinib (USAN/INN) D11970 Ritlecitinib tosylate (USAN); Ritlecitinib tosilate (JAN) D12118 Nezulcitinib (USAN) D12502 Golidocitinib (USAN/INN) D03203 Abatacept (USAN/INN); Abatacept (genetical recombination) (JAN) DG01936 TNF inhibitor D00742 Etanercept (USAN/INN); Etanercept (genetical recombination) (JAN); Etanercept (genetical recombination) [Etanercept biosimilar 1] (JAN); Etanercept (genetical recombination) [Etanercept biosimilar 2] (JAN) D02598 Infliximab (USAN/INN); Infliximab (genetical recombination) (JAN); Infliximab (genetical recombination) [Infliximab biosimilar 1] (JAN); Infliximab (genetical recombination) [Infliximab biosimilar 2] (JAN); Infliximab (genetical recombination) [Infliximab biosimilar 3] (JAN) D07436 Afelimomab (INN) D02597 Adalimumab (USAN/INN); Adalimumab (genetical recombination) (JAN); Adalimumab (genetical recombination) [Adalimumab biosimilar 1] (JAN); Adalimumab (genetical recombination) [Adalimumab biosimilar 2] (JAN); Adalimumab (genetical recombination) [Adalimumab biosimilar 3] (JAN); Adalimumab (genetical recombination) [Adalimumab biosimilar 4] (JAN) D03441 Certolizumab pegol (USAN/INN); Certolizumab pegol (genetical recombination) (JAN) D04358 Golimumab (USAN/INN); Golimumab (genetical recombination) (JAN) DG00744 Lenalidomide D04687 Lenalidomide (JAN/USAN/INN) D09813 Lenalidomide hydrate (JAN) D04690 Lenercept (USAN/INN) D05146 Nerelimomab (USAN/INN) D05263 Onercept (USAN/INN) D05393 Pegsunercept (USAN) D09944 Ozoralizumab (USAN); Ozoralizumab (genetical recombination) (JAN) D10187 Pateclizumab (USAN) D10320 Placulumab (USAN/INN) D02596 Tocilizumab (USAN/INN); Tocilizumab (genetical recombination) (JAN) D10161 Sarilumab (USAN); Sarilumab (genetical receombination) (JAN) D03684 Denosumab (USAN); Denosumab (genetical recombination) (JAN) |
| 上位グループ | Anti-inflammatory |
| 注釈1 | - |
| 注釈2 | - |